WEST LAFAYETTE, Ind., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company will host a conference call on Thursday, Nov. 1, at 4:30 p.m. EDT, to discuss its third quarter financial results and provide an operational update.
